Precision medicine: Statistical model can calculate potential success of new drugs

drug
Credit: CC0 Public Domain

The aim of "precision medicine" is to devise individualised treatment strategies and therapies. Statistical methods play an important role in predicting the efficacy of drugs from clinical study data, based on patient characteristics. A research team from MedUni Vienna's Institute of Medical Statistics has now presented new mathematical methods that efficiently identify the characteristics that are relevant for such predictions. These methods can also be used to calculate the range of statistical variation of these predictions.

We know that drugs do not have the same effect on everyone. Researchers in are therefore conducting to identify subgroups of who respond particularly well to the active agent and do not have an elevated risk of side-effects. This process is based on modern diagnostic techniques such as genome sequencing and molecular imaging.

The data derived from these studies will be used for statistical analyses to more accurately predict efficacy. This will involve statistical techniques to filter out relevant biomarkers from the plethora of data. These biomarkers are, for example, certain genetic mutations or laboratory values plus other patient characteristics such as age, gender or disease stage.

The biomarkers identified in this way can then be used to develop models to predict the subgroups of patients for whom treatment with a newly developed drug will be more effective than the standard treatment. For example, in cancer studies it is possible to predict in which patients a new drug might have a life-extending effect. So-called regression models and variable selection methods are used to do this. However, statistical predictions are always subject to a certain range of variation. The fewer data that are available from patients participating in studies, the less accurate the prediction will be. An aim in is therefore to minimise the range of variation to allow the most accurate possible prediction of the efficacy of a particular treatment.

The recently published research paper describes the design of new statistical methods to be used in the development of . Based on clinical studies, it is possible to use these algorithms to identify relevant biomarkers and to assess the statistical reliability of predictions. This means that, when developing new drugs, it is possible to predict more accurately the patient subgroups for whom treatment will be effective and safe. This is an important step towards improving the reliability of predictive models in precision medicine and assisting the development of individualised treatments.


Explore further

Cancer researchers propose new ways to select patients for clinical trials

More information: Nicolás M. Ballarini et al. Subgroup identification in clinical trials via the predicted individual treatment effect, PLOS ONE (2018). DOI: 10.1371/journal.pone.0205971
Journal information: PLoS ONE

Citation: Precision medicine: Statistical model can calculate potential success of new drugs (2018, November 7) retrieved 27 May 2019 from https://medicalxpress.com/news/2018-11-precision-medicine-statistical-potential-success.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more